Dina Lev

16.6k total citations
178 papers, 9.0k citations indexed

About

Dina Lev is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Dina Lev has authored 178 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 54 papers in Molecular Biology. Recurrent topics in Dina Lev's work include Sarcoma Diagnosis and Treatment (104 papers), Vascular Tumors and Angiosarcomas (33 papers) and Cardiac tumors and thrombi (24 papers). Dina Lev is often cited by papers focused on Sarcoma Diagnosis and Treatment (104 papers), Vascular Tumors and Angiosarcomas (33 papers) and Cardiac tumors and thrombi (24 papers). Dina Lev collaborates with scholars based in United States, Israel and Australia. Dina Lev's co-authors include Alexander J. Lazar, Raphael E. Pollock, Guy Lahat, Svetlana Bolshakov, Menashe Bar‐Eli, Wei‐Lien Wang, Peter W. T. Pisters, Daniel Tuvin, Janet E. Price and Dolores López‐Terrada and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dina Lev

176 papers receiving 8.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Lev United States 59 4.7k 3.3k 2.7k 1.8k 1.4k 178 9.0k
Heinrich Kovar Austria 47 4.5k 1.0× 2.0k 0.6× 4.0k 1.5× 962 0.5× 1.0k 0.7× 135 8.3k
Enrique de Álava Spain 40 3.8k 0.8× 1.9k 0.6× 2.7k 1.0× 1.2k 0.6× 899 0.6× 186 6.9k
Edwin Choy United States 50 4.0k 0.9× 2.8k 0.8× 3.2k 1.2× 2.0k 1.1× 642 0.4× 203 8.5k
Maria Dêbiec‐Rychter Belgium 59 7.5k 1.6× 2.7k 0.8× 2.4k 0.9× 2.2k 1.2× 649 0.5× 318 12.3k
Katia Scotlandi Italy 55 3.6k 0.8× 2.8k 0.8× 5.0k 1.8× 830 0.5× 479 0.3× 270 9.4k
Elena Tamborini Italy 44 3.3k 0.7× 1.8k 0.5× 1.1k 0.4× 1.5k 0.8× 442 0.3× 144 5.6k
Ola Myklebost Norway 51 2.8k 0.6× 2.5k 0.8× 4.9k 1.8× 504 0.3× 382 0.3× 175 9.0k
Bruce Pawel United States 36 1.7k 0.4× 1.3k 0.4× 2.2k 0.8× 594 0.3× 421 0.3× 139 5.1k
Sakari Knuutila Finland 54 3.2k 0.7× 2.1k 0.6× 4.0k 1.4× 666 0.4× 314 0.2× 249 9.5k
Christopher Poremba Germany 54 2.2k 0.5× 2.5k 0.8× 3.0k 1.1× 378 0.2× 323 0.2× 166 7.7k

Countries citing papers authored by Dina Lev

Since Specialization
Citations

This map shows the geographic impact of Dina Lev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Lev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Lev more than expected).

Fields of papers citing papers by Dina Lev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Lev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Lev. The network helps show where Dina Lev may publish in the future.

Co-authorship network of co-authors of Dina Lev

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Lev. A scholar is included among the top collaborators of Dina Lev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Lev. Dina Lev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casadei, Lucia, Federica Calore, Danielle Braggio, et al.. (2019). MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes. Cancer Research. 79(19). 4911–4922. 26 indexed citations
2.
Casadei, Lucia, Federica Calore, Chad J. Creighton, et al.. (2017). Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression. Cancer Research. 77(14). 3846–3856. 149 indexed citations
3.
Bill, Kate Lynn J., Jeannine Garnett, Isabelle Meaux, et al.. (2015). SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clinical Cancer Research. 22(5). 1150–1160. 86 indexed citations
4.
Phung, Thuy L., Wa Du, Qi Xue, et al.. (2014). Akt1 and Akt3 Exert Opposing Roles in the Regulation of Vascular Tumor Growth. Cancer Research. 75(1). 40–50. 40 indexed citations
5.
Wang, Wei‐Lien, et al.. (2012). CTNNB1 Genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Algorithm. Pediatric and Developmental Pathology. 15(5). 361–367. 34 indexed citations
6.
Zhang, Pingyu, Katelynn Bill, Juehui Liu, et al.. (2012). MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin Signaling. Cancer Research. 72(7). 1751–1762. 100 indexed citations
7.
Yang, Jinming, Sara Kantrow, Jiqing Sai, et al.. (2012). Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma. Cancer Research. 72(18). 4682–4695. 30 indexed citations
8.
Ghadimi, Markus P., Eric D. Young, Roman Belousov, et al.. (2012). Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 18(9). 2545–2557. 36 indexed citations
9.
Savannah, Kari J. Brewer, Dafydd G. Thomas, Kunle Odunsi, et al.. (2012). A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma. Clinical Cancer Research. 18(12). 3352–3365. 49 indexed citations
10.
Savannah, Kari J. Brewer, Elizabeth G. Demicco, Kristelle Lusby, et al.. (2012). Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma. Clinical Cancer Research. 18(17). 4633–4645. 40 indexed citations
11.
Zimmerman, Mary Ann, Nur-Taz Rahman, Dafeng Yang, et al.. (2012). Unphosphorylated STAT1 Promotes Sarcoma Development through Repressing Expression of Fas and Bad and Conferring Apoptotic Resistance. Cancer Research. 72(18). 4724–4732. 38 indexed citations
12.
Lopez, Gonzalo, Keila E. Torres, & Dina Lev. (2011). Autophagy blockade enhances HDAC inhibitors’ pro-apoptotic effects. Autophagy. 7(4). 440–441. 36 indexed citations
13.
Xie, Xianbiao, Markus P. Ghadimi, Eric D. Young, et al.. (2011). Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma. Clinical Cancer Research. 17(18). 5901–5912. 34 indexed citations
14.
Torres, Keila E., Quansheng Zhu, Katelynn Bill, et al.. (2011). Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 17(12). 3943–3955. 74 indexed citations
15.
Yang, Jilong, Antti Ylipää, Yan Sun, et al.. (2011). Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment. Clinical Cancer Research. 17(24). 7563–7573. 44 indexed citations
16.
Dumont, Agathe, Lori Rink, Andrew K. Godwin, et al.. (2011). A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Annals of Oncology. 23(5). 1335–1340. 33 indexed citations
17.
Colombo, Chiara, Chad J. Creighton, Markus P. Ghadimi, et al.. (2011). Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. The Journal of Pathology. 225(4). 574–582. 18 indexed citations
18.
Johnson, Jay E., Neil Beeharry, Maria Chiourea, et al.. (2010). Doxorubicin Resistance in a Novel In vitro Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres. Molecular Cancer Therapeutics. 9(3). 682–692. 8 indexed citations
19.
Lazar, Alexander J., et al.. (2009). Desmoid tumor: from surgical extirpation to molecular dissection. Current Opinion in Oncology. 21(4). 352–359. 36 indexed citations
20.
Ren, Wenhong, Borys Korchin, Quansheng Zhu, et al.. (2008). Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo. Clinical Cancer Research. 14(9). 2785–2795. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heinrich Kovar Breakdown of academic impact, for papers by Enrique de Álava Breakdown of academic impact, for papers by Edwin Choy Breakdown of academic impact, for papers by Maria Dêbiec‐Rychter Breakdown of academic impact, for papers by Katia Scotlandi Breakdown of academic impact, for papers by Elena Tamborini Breakdown of academic impact, for papers by Ola Myklebost Breakdown of academic impact, for papers by Bruce Pawel Breakdown of academic impact, for papers by Sakari Knuutila Breakdown of academic impact, for papers by Christopher Poremba
Rankless by CCL
2026